Matches in Wikidata for { <http://www.wikidata.org/entity/Q66027313> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66027313 description "clinical trial" @default.
- Q66027313 description "ensayu clínicu" @default.
- Q66027313 description "klinisch onderzoek" @default.
- Q66027313 description "клінічне випробування" @default.
- Q66027313 name "Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer" @default.
- Q66027313 name "Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer" @default.
- Q66027313 type Item @default.
- Q66027313 label "Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer" @default.
- Q66027313 label "Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer" @default.
- Q66027313 prefLabel "Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer" @default.
- Q66027313 prefLabel "Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer" @default.
- Q66027313 P1132 Q66027313-31CC82F2-30C5-4477-A0E7-06A868CF505B @default.
- Q66027313 P1476 Q66027313-D482F7DB-70D5-4BDB-B9B3-B9C9D57F1F2D @default.
- Q66027313 P17 Q66027313-047D2797-356A-43E0-9930-3BB60E65943B @default.
- Q66027313 P1813 Q66027313-B56F87DC-A915-40F3-9BC3-0B477A962173 @default.
- Q66027313 P2899 Q66027313-759BE81F-42B3-4521-918E-BE877B1F544B @default.
- Q66027313 P3098 Q66027313-6B823528-5258-4E27-BF2E-111A0A2111E0 @default.
- Q66027313 P31 Q66027313-FFAEE772-EB57-4756-BD37-EF7BAEDB5920 @default.
- Q66027313 P580 Q66027313-C7D119EB-E692-4D8E-A86C-A22592EFF991 @default.
- Q66027313 P582 Q66027313-A93BE10C-F230-4071-A8B8-BDCB0B538E4F @default.
- Q66027313 P6099 Q66027313-15A5F760-2F4D-4058-964D-FC044E2FD48C @default.
- Q66027313 P6153 Q66027313-D238F9D0-E227-40B6-829E-6D3271C95725 @default.
- Q66027313 P8363 Q66027313-08310DE3-9927-466A-AC01-0892336FAADE @default.
- Q66027313 P859 Q66027313-05CEAE87-C628-4D93-9E4C-65BE76856732 @default.
- Q66027313 P1132 "+93" @default.
- Q66027313 P1476 "An Open Label, Randomized Comparison of Femara® 2.5mg Once Daily With or Without Weekly Herceptin® Until Disease Progression as First-line Treatment in Postmenopausal Women With Advanced Breast Cancer." @default.
- Q66027313 P17 Q183 @default.
- Q66027313 P1813 "eLEcTRA" @default.
- Q66027313 P2899 "+18" @default.
- Q66027313 P3098 "NCT00171847" @default.
- Q66027313 P31 Q30612 @default.
- Q66027313 P580 "2003-03-01T00:00:00Z" @default.
- Q66027313 P582 "2008-10-01T00:00:00Z" @default.
- Q66027313 P6099 Q42825046 @default.
- Q66027313 P6153 Q507154 @default.
- Q66027313 P8363 Q78089383 @default.
- Q66027313 P859 Q507154 @default.